Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: A case-control study
- 31 October 1996
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 132 (4) , 790-795
- https://doi.org/10.1016/s0002-8703(96)90313-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patientsThe American Journal of Medicine, 1994
- A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosusAmerican Heart Journal, 1993
- Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodiesJournal of the American College of Cardiology, 1992
- Cardiovascular Disease in Systemic Lupus Erythematosus A Study of 75 Patients from a Defined PopulationMedicine, 1992
- Valvular Heart Disease in the Primary Antiphospholipid SyndromeAnnals of Internal Medicine, 1992
- Cardiac involvement in patients with primary antiphospholipid syndromeJournal of the American College of Cardiology, 1991
- Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies.Circulation, 1990
- Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosusThe Lancet, 1990
- Lupus anticoagulant: a clinical and laboratory study of 100 casesClinical and Laboratory Haematology, 1988
- A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITISArchives of internal medicine (1960), 1924